Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPd in Relapsed/Refractory Multiple Myeloma
NCT02185820Phase 2Completed
- Start
- Jun 2014
- Primary completion
- Jul 2015
- Modality
- Reversible Covalent Inhibitors, Irreversible Covalent Inhibitors, Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib, pomalidomide in multiple myeloma (MM). Started Jun 2014; status: completed.
02
Drugs
carfilzomibpomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02185820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185820.